Axon price target raised to $300 from $235 at Northland

Northland raised the firm’s price target on Axon to $300 from $235 and keeps an Outperform rating on the shares. Q4 revenue grew 28%, and the year 31%, says the analyst, who notes that Axon just recorded its fifth consecutive year of over 25% growth. Bookings were “strong again, largely across the board,” added the analyst, who is increasing the firm’s FY24 EBITDA estimate following the report.